Evidence map›Paper›PMID 41053184›Full record

ArticleScientific reports2025

Comprehensive evaluation of medical quality and analysis of obstacle factors in specialized neurological hospitals based on a multi-dimensional evaluation model: a case study of China's National Regional Medical Center for Neurological Diseases.

Qian Liu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Qian LiuTianjin Huanhu Hospital, Tianjin, China. aliuqian2020@163.com.

Funding

Tianjin Municipal Health Commission TJWJ2023QN057
6 · The paper itself

Abstract

The present study establishes a comprehensive evaluation system for assessing medical quality in specialized neurological hospitals, developed based on the performance indicators of national tertiary public hospitals. The system comprises 5 dimensions and 14 sub-indicators, carefully selected through rigorous consideration of three key factors: policy compliance, professional suitability, and targeted management needs.To ensure robust evaluation, we employed a combined methodological approach utilizing both entropy-weighted TOPSIS and RSR methods, with cross-validation of results demonstrating strong consistency between the two techniques. The analysis revealed Ci values ranging from 0.405 to 0.653 and RSR values spanning 0.486 to 0.793, with 2023 emerging as the highest-performing year and 2020 ranking lowest in terms of overall medical quality.Through obstacle degree analysis, we identified critical limiting factors affecting hospital performance. While obstacles related to medical service volume showed a welcome decline, we observed concerning increases in operational efficiency barriers. Notably, indicators within the medical safety dimension consistently ranked as the most significant obstacles throughout the study period.The longitudinal analysis from 2019 to 2023 demonstrates progressive improvement in the hospital's overall medical quality, particularly in addressing service volume challenges. However, the upward trends in social evaluation and operational efficiency obstacles, coupled with persistent medical safety concerns, highlight areas requiring ongoing management attention and targeted intervention strategies.

Indexed as

Nervous System DiseasesQuality of Health CareTertiary Care CentersChinaHospitals, PublicHumansQuality Indicators, Health CareEntropy-weighted TOPSIS methodMedical qualityObstacle degree analysisRSR methodSpecialized neurological hospital

Identifiers

PMID41053184
PMCPMC12500937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.